H. Gunn

Phase 1 Trial of Subcutaneous IL-6 in Patients With Refractory Cancer: Clinical and Biologic Effects

G. T. Budd, T. Olencki, J. Finke, 2000, Journal of immunotherapy.

Workshop on Bioanalytical Methods Validation for Macromolecules: Summary Report

Krys J. Miller, Michael Geier, Steve J. Swanson, 2001, Pharmaceutical Research.

Pharmacodynamics of daily subcutaneous recombinant human interleukin‐3 in normal volunteers

J. Seibold, D. Resta, L. Myers, 1995, Clinical pharmacology and therapeutics.

ELISA methodology for detection of modified osteoprotegerin in clinical studies.

J. Young, N. A. Sarıkaya, H. Gunn, 2001, Clinical chemistry.

ELISA Methodology for Detection of Modified Osteo- protegerin in Clinical Studies, De Chen, * Nihal A.

Steven W. Martin, J. Young, H. Gunn, 2001 .

Method transfer for ligand-binding assays: recommendations for best practice.

Judy Y Shih, Vimal Patel, Danielle DeSimone, 2011, Bioanalysis.

Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.

Binodh DeSilva, Mark Ma, Lennie Uy, 2009, Journal of pharmaceutical and biomedical analysis.